Legal Representation
Attorney
Christopher N. Bolinger
Application History
28 events| Date | Code | Type | Description |
|---|---|---|---|
| Apr 5, 2007 | ABN1 | S | ABANDONMENT - EXPRESS MAILED |
| Apr 5, 2007 | MAB1 | O | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT |
| Apr 5, 2007 | ABN1 | S | ABANDONMENT - EXPRESS MAILED |
| Apr 5, 2007 | MAB1 | O | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT |
| Apr 3, 2007 | I | PAPER RECEIVED | |
| Apr 3, 2007 | I | PAPER RECEIVED | |
| Nov 28, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Nov 28, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Sep 5, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Sep 5, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Aug 16, 2006 | NPUB | O | NOTICE OF PUBLICATION |
| Aug 16, 2006 | NPUB | O | NOTICE OF PUBLICATION |
| Jul 11, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Jul 11, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Jul 7, 2006 | ALIE | A | ASSIGNED TO LIE |
| Jul 7, 2006 | ALIE | A | ASSIGNED TO LIE |
| Jul 5, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jul 5, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jun 16, 2006 | CNEA | F | EXAMINER'S AMENDMENT MAILED |
| Jun 16, 2006 | CNEA | F | EXAMINER'S AMENDMENT MAILED |
| Jun 15, 2006 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jun 15, 2006 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Jun 15, 2006 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jun 15, 2006 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Jun 14, 2006 | DOCK | D | ASSIGNED TO EXAMINER |
| Jun 14, 2006 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 21, 2005 | NWAP | I | NEW APPLICATION ENTERED IN TRAM |
| Dec 21, 2005 | NWAP | I | NEW APPLICATION ENTERED IN TRAM |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, premature ejaculation, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations namely, cholesterol preparations, insomnia preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations and ophthalmological preparations
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005